keyword
https://read.qxmd.com/read/38415359/practice-changing-clinical-trials-in-radiation-oncology-for-gastrointestinal-malignancies-in-2021-2023
#21
REVIEW
J Boustani, F Huguet, V Vendrely
Gastrointestinal cancers are one of the most frequent cancers and a leading cause of cancer deaths worldwide. We provide an overview of the most important practice-changing trials that were either published or presented at the international scientific meetings in 2021-2023. Highlights included reports on three phase III trials (CONCORDE/PRODIGE 26, ARTDECO, and a study by Xu et al.) that evaluated dose escalation in the definitive setting for locally advanced oesophageal cancers, as well as two phase III trials that evaluated the role of chemotherapy (neo-AEGIS) and targeted therapy (NRG/RTOG 1010) in the neoadjuvant setting for adenocarcinoma oesophageal cancers or gastroesophageal junction cancer...
December 2023: Cancer Radiothérapie: Journal de la Société Française de Radiothérapie Oncologique
https://read.qxmd.com/read/38399534/assessment-of-radiation-dosage-to-the-hippocampi-during-treatment-of-multiple-brain-metastases-using-gamma-knife-therapy
#22
JOURNAL ARTICLE
Maciej Laskowski, Bartłomiej Błaszczyk, Marcin Setlak, Maciej Kuca, Arkadiusz Lech, Kamil Kłos, Adam Rudnik
Background and Objectives: Brain metastases (BMs) pose significant clinical challenges in systemic cancer patients. They often cause symptoms related to brain compression and are typically managed with multimodal therapies, such as surgery, chemotherapy, whole brain radiotherapy (WBRT), and stereotactic radiosurgery (SRS). With modern oncology treatments prolonging survival, concerns about the neurocognitive side effects of BM treatments are growing. WBRT, though widely used for multiple BMs, has recognized neurocognitive toxicity...
January 31, 2024: Medicina
https://read.qxmd.com/read/38393390/csmed-%C3%A2-wound-dressing-for-prophylaxis-and-management-of-radiation-dermatitis-in-breast-and-head-neck-cancer-patients-a-single-hospital-prospective-clinical-trial
#23
JOURNAL ARTICLE
Yueh-Chun Lee, Hsien-Chun Tseng, Huei-Fang Yang, Yi-Hung Lee, Ya-Fang Ko, Shin-Tsung Chang, Hsin-Lin Chen, Bo-Jiun Chang, Ying-Hsiang Chou
PURPOSE: CSMed® wound dressing, a dressing with various herb extracts, was tested for its therapeutic effect in radiation dermatitis of breast and head-and-neck cancer patients. METHODS: This study included 20 breast cancer patients and 10 head-and-neck cancer patients. Half of the irradiated area was covered with CSMed® and the other half was under routine treatment. The severity of radiation dermatitis was evaluated with radiation therapy oncology group (RTOG) grade throughout the treatment and the follow-up period...
February 23, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38390032/reassessing-the-efficacy-of-bevacizumab-in-newly-diagnosed-glioblastoma-a-systematic-review-and-external-pseudodata-based-analysis
#24
REVIEW
Giacomo Sferruzza, Massimo Malcangi, Luca Bosco, Gaetano Finocchiaro
BACKGROUND: First-line use of bevacizumab for glioblastoma (GBM) was evaluated in 2 phase 3 randomized controlled trials (RCT), demonstrating an impact on progression-free survival but not overall survival (OS). However, the crossover events of these trials raised concerns regarding the reliability of this latter analysis. In this study, we conducted an external control-based reassessment of the bevacizumab efficacy in newly diagnosed GBM (ndGBM) against the standard Stupp protocol. METHODS: A systematic review of the literature was conducted to identify the phase 3 RCTs in ndGBM incorporating the Stupp protocol as an arm...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38360049/need-for-objective-task-based-evaluation-of-image-segmentation-algorithms-for-quantitative-pet-a-study-with-acrin-6668-rtog-0235-multicenter-clinical-trial-data
#25
JOURNAL ARTICLE
Ziping Liu, Joyce C Mhlanga, Huitian Xia, Barry A Siegel, Abhinav K Jha
Reliable performance of PET segmentation algorithms on clinically relevant tasks is required for their clinical translation. However, these algorithms are typically evaluated using figures of merit (FoMs) that are not explicitly designed to correlate with clinical task performance. Such FoMs include the Dice similarity coefficient (DSC), the Jaccard similarity coefficient (JSC), and the Hausdorff distance (HD). The objective of this study was to investigate whether evaluating PET segmentation algorithms using these task-agnostic FoMs yields interpretations consistent with evaluation on clinically relevant quantitative tasks...
February 15, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38359280/factors-associated-with-the-quality-of-life-of-women-undergoing-radiotherapy
#26
JOURNAL ARTICLE
Fabiane Diniz Machado Vilhena, Odenilce Vieira Pereira, Fabianne de Jesus Dias de Sousa, Nandara Celana Negreiros Martins, Gisela Pereira Xavier Albuquerque, Renata Glaucia Barros da Silva Lopes, Taís Dos Passos Sagica, Aline Maria Pereira Cruz Ramos
OBJECTIVE: To evaluate the skin characteristics and quality of life of patients with breast cancer undergoing radiotherapy. METHOD: Cross-sectional study conducted with 60 women. The classification scales of skin changes resulting from exposure to ionizing radiation (RTOG) and the validated versions in Portuguese of those that classified skin types (Fitzpatrick), symptoms (RISRAS) and quality of life (DLQI) were applied. in the period between December 2021 and October 2022...
2024: Revista Gaúcha de Enfermagem
https://read.qxmd.com/read/38307806/cardiovascular-mortality-and-duration-of-androgen-deprivation-in-locally-advanced-prostate-cancer-long-term-update-of-nrg-rtog-9202
#27
JOURNAL ARTICLE
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, William U Shipley, Yue Lin, Christopher A Peters, Elizabeth M Gore, Seth A Rosenthal, Kenneth L Zeitzer, David P D'Souza, Eric M Horwitz, Thomas M Pisansky, Jordan M Maier, Susan M Chafe, Tyler P Robin, Mack Roach, Phuoc T Tran, Luis Souhami, Jeff M Michalski, Alan C Hartford, Felix Y Feng, Howard M Sandler, Jason A Efstathiou
BACKGROUND: Androgen deprivation therapy (ADT) has been associated with coronary heart disease and myocardial infarction (MI) in prostate cancer patients, but controversy persists regarding its effects on cardiovascular mortality (CVM). OBJECTIVE: We assessed the long-term relationship between ADT and CVM in a prostate cancer randomized trial (NRG Oncology/Radiation Therapy Oncology Group 9202). DESIGN, SETTING, AND PARTICIPANTS: From 1992 to 1995, 1554 men with locally advanced prostate cancer (T2c-T4, prostate-specific antigen <150 ng/ml) received radiotherapy with 4 mo (short-term [STADT]) versus 28 mo (longer-term [LTADT]) of ADT...
February 1, 2024: European Urology Focus
https://read.qxmd.com/read/38302323/external-validation-of-a-digital-pathology-based-multimodal-artificial-intelligence-architecture-in-the-nrg-rtog-9902-phase-3-trial
#28
JOURNAL ARTICLE
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass, Jeffry P Simko, Sandy DeVries, Todd M Morgan, Luis Souhami, Michael C Dobelbower, L Scott McGinnis, Christopher U Jones, Robert T Dess, Kenneth L Zeitzer, Kwang Choi, Alan C Hartford, Jeff M Michalski, Adam Raben, Leonard G Gomella, A Oliver Sartor, Seth A Rosenthal, Howard M Sandler, Daniel E Spratt, Stephanie L Pugh, Osama Mohamad, Andre Esteva, Emmalyn Chen, Edward M Schaeffer, Phuoc T Tran, Felix Y Feng
BACKGROUND: Accurate risk stratification is critical to guide management decisions in localized prostate cancer (PCa). Previously, we had developed and validated a multimodal artificial intelligence (MMAI) model generated from digital histopathology and clinical features. Here, we externally validate this model on men with high-risk or locally advanced PCa treated and followed as part of a phase 3 randomized control trial. OBJECTIVE: To externally validate the MMAI model on men with high-risk or locally advanced PCa treated and followed as part of a phase 3 randomized control trial...
January 31, 2024: European Urology Oncology
https://read.qxmd.com/read/38236375/simultaneous-integrated-boost-sib-versus-sequential-boost-in-anal-cancer-patients-a-single-center-experience
#29
JOURNAL ARTICLE
Divya Khosla, Rakesh Kapoor, Treshita Dey, Vaishali Kataria, Ranjit Singh, Divyesh Kumar, Arun Singh Oinam, Rajesh Gupta, Surinder Singh Rana, Jimil Shah, Harjeet Singh, Santhosh Irrinki, Renu Madan
PURPOSE: Concurrent chemoradiation is the standard of care for the treatment of anal cancer. Radiation can be delivered by sequential or simultaneous integrated boost (SIB) approach. The present study was conducted to compare the treatment outcomes and toxicity profile of patients with anal cancer treated with sequential boost and SIB approach. METHODS: A single-institution retrospective analysis of patients with squamous cell carcinoma of the anal canal treated between 2019 and 2022 with radical chemoradiation was performed...
January 18, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38204729/how-to-contour-the-different-heart-subregions-for-future-deep-learning-modeling-of-the-heart-a-practical-pictorial-proposal-for-radiation-oncologists
#30
JOURNAL ARTICLE
Loig Vaugier, Elvire Martin-Mervoyer, Loic Ah-Thiane, Martin Langé, Luc Ollivier, Tanguy Perennec, Stéphane Supiot, Loig Duvergé, François Lucia, Pierre Trémolières, Roshanack Movassaghi, Karine Fresse-Warin, Alexandra Moignier, Francois Thillays
There are currently no accurate rules for manually delineating the subregions of the heart (cavities, vessels, aortic/mitral valves, Planning organ at Risk Volumes for coronary arteries) with the perspective of deep-learning based modeling. Our objective was to present a practical pictorial view for radiation oncologists, based on the RTOG atlas and anatomical complementary considerations for the cases where the RTOG guidelines are missing.
March 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38195438/adjuvant-medial-versus-entire-supraclavicular-lymph-node-irradiation-in-high-risk-early-breast-cancer-suclanode-a-protocol-for-a-multicenter-randomized-open-label-phase-3-trial
#31
JOURNAL ARTICLE
Li Zhang, Xin Mei, Zhigang Hu, Bo Yu, Chaoyang Zhang, Yong Li, Kaitai Liu, Xuejun Ma, Jinli Ma, Xingxing Chen, Jin Meng, Wei Shi, Xiaofang Wang, Miao Mo, Zhimin Shao, Zhen Zhang, Xiaoli Yu, Xiaomao Guo, Zhaozhi Yang
BACKGROUND: Supraclavicular nodal (SCL) irradiation is commonly used for patients with high-risk breast cancer after breast surgery. The Radiation Therapy Oncology Group (RTOG) and European Society for Radiotherapy and Oncology (ESTRO) breast contouring atlases delineate the medial part of the SCL region, while excluding the posterolateral part. However, recent studies have found that a substantial proportion of SCL failures are located in the posterolateral SCL region, outside of the RTOG/ESTRO-defined SCL target volumes...
January 9, 2024: BMC Cancer
https://read.qxmd.com/read/38194100/dosimetric-and-radiobiological-comparison-of-imrt-vmat-and-helical-tomotherapy-planning-techniques-in-hippocampal-sparing-whole-brain-radiotherapy-with-simultaneous-integrated-boost-for-multiple-brain-metastases
#32
JOURNAL ARTICLE
S Balasubramanian, M K Shobana, D Anabalagan, P Thanasekar, S Joel, Prekshi Chaudhary
To compare treatment planning and dosimetric outcomes for hippocampal sparing whole brain radiotherapy (WBRT) with the simultaneous integrated boost (SIB) in brain metastasis (BM) patients using tumour control probability (TCP) and normal tissue complication probability (NTCP) formalism between IMRT, VMAT, and HT techniques. In this retrospective study, the treatment data of 20 BM patients who typically received whole brain radiation with SIB treatment were used. Prescription doses of 30 Gy and 36 Gy was delivered in 10 fractions for WBRT and SIB, respectively...
January 9, 2024: Radiation and Environmental Biophysics
https://read.qxmd.com/read/38192583/dose-volume-relationships-of-planned-versus-estimated-delivered-radiation-doses-to-pelvic-organs-at-risk-and-side-effects-in-patients-treated-with-salvage-radiotherapy-for-recurrent-prostate-cancer
#33
JOURNAL ARTICLE
Vilberg Jóhannesson, Adalsteinn Gunnlaugsson, Per Nilsson, Patrik Brynolfsson, Elisabeth Kjellén, Elinore Wieslander
PURPOSE: To investigate estimated delivered dose distributions using weekly cone-beam computed tomography (CBCT) scans for pelvic organs at risk (OARs) in salvage radiotherapy (SRT) after radical prostatectomy. Furthermore, to compare them with the originally planned dose distributions and analyse associations with gastrointestinal (GI) and genitourinary (GU) side effects. METHODS: This study is part of a phase II trial involving SRT for recurrent prostate cancer...
March 2024: Technical innovations & patient support in radiation oncology
https://read.qxmd.com/read/38186361/randomized-pilot-study-of-a-keratin-based-topical-cream-for-radiation-dermatitis-in-breast-cancer-patients
#34
RANDOMIZED CONTROLLED TRIAL
Karen M Winkfield, Ryan T Hughes, Doris R Brown, Ryan M Clohessy, Robert C Holder, Gregory B Russell, Alexis F Rejeski, Luke R Burnett
Purpose: Radiotherapy (RT) is commonly used in the treatment of breast cancer and often, despite advances in fractionated dosing schedules, produces undesirable skin toxicity. The purpose of this study was to evaluate the feasibility of using a keratin-based topical cream, KeraStat® Cream (KC; KeraNetics, Inc., Winston Salem, NC, USA) to manage the symptoms of radiation dermatitis (RD) in breast cancer patients undergoing RT. Materials and Methods: A total of 24 subjects were enrolled on this single-center, randomized, open-label study...
2024: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/38167339/hypofractionated-adjuvant-radiotherapy-in-1-versus-2-weeks-in-high-risk-patients-with-breast-cancer-hypart-a-non-inferiority-open-label-phase-iii-randomised-trial
#35
RANDOMIZED CONTROLLED TRIAL
Budhi Singh Yadav, Divya Dahiya, P Kannan, Shikha Goyal, Ishita Laroiya, Santhosh Irrinki, Ngangom Robert Singh, Reena Sharma
BACKGROUND: Breast cancer is the most common cancer in women. Radiotherapy is an important part of breast cancer treatment after surgery. Breast cancer radiotherapy is usually delivered in 3-5 weeks. This is a long duration for women with breast cancer to stay away from the family and work. We wanted to reduce this duration so that the wages loss and the logistics can be minimised for these patients. Hypofractionation, i.e. high dose per fraction, is delivered in a smaller number of days...
January 2, 2024: Trials
https://read.qxmd.com/read/38159264/amelioration-of-acute-radiation-dermatitis-in-breast-cancer-patients-by-a-bioadhesive-barrier-forming-gel-episil%C3%A2-a-single-center-open-parallel-randomized-phase-i-ii-controlled-trial
#36
JOURNAL ARTICLE
Qian Li, Shanhui Feng, Zeshun Yu, Yue Wang, Lijun Tian, Haitao Geng, Chen Guo, Fangling Ning, Judong Luo, Changmin Liu
Episil® is a bioadhesive barrier-forming liquid gel that can relieve mucositis caused by radiotherapy (RT) and effectively relieve pain. The purpose of this trial is to compare the efficacy and safety of Episil® in improving acute radiation dermatitis (ARD) in breast cancer patients. This study included patients who met the criteria for postoperative radiotherapy for breast cancer. The primary endpoint was the grade of radiation dermatitis during treatment. A total of 102 patients were included in this study...
December 30, 2023: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38152364/individualized-3d-printed-bolus-promotes-precise-postmastectomy-radiotherapy-in-patients-receiving-breast-reconstruction
#37
JOURNAL ARTICLE
Jun Wang, Zhong-Zheng Xiang, Chen-Feng Tan, Yuan-Yuan Zeng, Tian Yang, Xiao-Yuan Wei, Si-Ting Yu, Ze-Lei Dai, Ning-Yue Xu, Lei Liu
PURPOSE: To evaluate the efficacy and safety of 3D-printed tissue compensations in breast cancer patients receiving breast reconstruction and postmastectomy radiotherapy (PMRT). METHODS AND MATERIALS: We enrolled patients with breast cancer receiving breast reconstruction and PMRT. The dose distribution of target and skin, conformability, and dose limit of organs at risk (OARs) were collected to evaluate the efficacy of the 3D-printed bolus. Radiation Therapy Oncology Group (RTOG) radiation injury classification was used to evaluated the skin toxicities...
2023: Frontiers in Oncology
https://read.qxmd.com/read/38101486/impact-of-apolipoprotein-e-apoe-genotype-on-neurocognitive-function-ncf-in-patients-with-brain-metastasis-bm-an-analysis-of-nrg-oncology-s-rtog-0614
#38
JOURNAL ARTICLE
Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, David R Grosshans, Erik P Sulman, Jane H Cerhan, Minesh P Mehta, Deepak Khuntia, Wenyin Shi, Mark V Mishra, John H Suh, Nadia N Laack, Yuhchyau Chen, Amarinthia Amy Curtis, Joanna M Laba, Ahmed Elsayed, Anu Thakrar, Stephanie L Pugh, Deborah W Bruner
PURPOSE: Whole brain radiotherapy (WBRT) is a common treatment for brain metastases (BM) and is frequently associated with decline in neurocognitive functioning (NCF). The e4 allele of the apolipoprotein E (APOE) gene is associated with increased risk of Alzheimer's disease, and NCF decline associated with a variety of neurologic diseases and insults. APOE carrier status has not been evaluated as a risk factor for onset-time or extent of NCF impairment in patients with BM treated with WBRT...
December 13, 2023: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38082467/remarkable-effects-of-infliximab-on-severe-radiation-induced-side-effects-in-a-patient-with-uterine-cervical-cancer-a-case-report
#39
JOURNAL ARTICLE
Amelie Toft Morén, Cecilia Bull, Karin Bergmark
Pelvic radiotherapy is a powerful treatment for a broad range of cancers, including gynecological, prostate, rectal, and anal cancers. Despite improvements in the delivery of ionizing beams, damage to non-cancerous tissue can cause long-term effects that are potentially severe, affecting quality of life and daily function. There is an urgent need for new strategies to treat and reverse the side effects of pelvic radiotherapy without compromising the antitumor effect. A woman with severe radiation-induced intestinal side effects was treated with the tumor necrosis factor-alpha inhibitor infliximab with a dose of 3 mg/kg every 4 to 6 weeks...
December 2023: Journal of International Medical Research
https://read.qxmd.com/read/38047214/elective-nodal-irradiation-for-oligorecurrent-nodal-prostate-cancer-interobserver-variability-in-the-peace-v-storm-randomized-phase-2-trial
#40
JOURNAL ARTICLE
Orane Lorton, Vérane Achard, Nikolaos Koutsouvelis, Maud Jaccard, Frederik Vanhoutte, Giovanna Dipasquale, Piet Ost, Thomas Zilli
PURPOSE: Consistency in delineation of pelvic lymph node regions for prostate cancer elective nodal radiation therapy is still challenging despite current guidelines. The aim of this study was to evaluate the interobserver variability in elective lymph node delineation in the PEACE V  - STORM randomized phase 2 trial for oligorecurrent nodal prostate cancer. METHODS AND MATERIALS: Twenty-three centers were asked to delineate the elective pelvic nodal clinical target volume (CTV) of a postoperative oligorecurrent nodal prostate cancer benchmark case using a modified Radiation Therapy Oncology Group (RTOG) 2009 template (upper limit at the L4/L5 interspace)...
2023: Advances in Radiation Oncology
keyword
keyword
43154
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.